Skip to main content
Figure 3 | BMC Infectious Diseases

Figure 3

From: Activity of the Bacillus anthracis20 kDa protective antigen component

Figure 3

Western blot comparison of recombinant PA 20 from the PA/Factor Xa mutant (lanes 1–4) and the commercial PA 17 (lanes 5–7) product at quantities varying from 1 to 5 μg of the purified rPA 20 Factor Xa and the LIST PA 17 . Purified 83 kDa PA/Factor Xa was treated for 30 min at 37°C with bovine plasma Factor Xa resulting in PA20 and PA63 kDa fragments. LF was added and allowed to oligomerize with the PA63 at room temperature for 15 minutes. The mixture was applied to Superose 6 size exclusion column (Amersham-Pharmacia) in PBS and resulted in 3 peaks. The rPA20 was further purified by Immuno-affinity.

Back to article page